Doximity (DOCS-N)
NYSE:DOCS
52.85
1.28
(2.48%) 1d
Financials
Technical Analysis
Up 38% since IPO in fall 2021. Shares got killed last year during inflation and rate hikes. Has since rebounded. It's been a round trip. Their last report was solid, but guidance was ugly, given a delay in their new telemedicine product given regulatory interference. But they've beaten every quarter. Pricey at 47x PE 2023 but are profitable.
- «
- ‹
- 1
- ›
- »
Doximity(DOCS-N) Rating
Ranking : 3 out of 5
Bullish - Buy Signals / Votes : 0
Neutral - Hold Signals / Votes : 1
Bearish - Sell Signals / Votes : 0
Total Signals / Votes : 1
Doximity(DOCS-N) Frequently Asked Questions
What is Doximity stock symbol?
Doximity is a American stock, trading under the symbol DOCS-N on the New York Stock Exchange (DOCS). It is usually referred to as NYSE:DOCS or DOCS-N
Is Doximity a buy or a sell?
In the last year, 1 stock analyst published opinions about DOCS-N. 0 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for Doximity.
Is Doximity a good investment or a top pick?
Doximity was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Doximity.
Why is Doximity stock dropping?
Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.
Is Doximity worth watching?
In the last year, there was no coverage of Doximity published on Stockchase.
What is Doximity stock price?
On 2025-04-11, Doximity (DOCS-N) stock closed at a price of $52.85.
DOCS has erased earlier gains from its last earnings report, amid the market drawdown, but it continues to be on a long-term uptrend, and forward sales and earnings estimates are strong. Analyst estimates have been trending higher in the past year, margins have been expanding, and it generates decent cash flows. It has a good balance sheet, but it is not cheap at 38X forward earnings. For a long-term investor, we would be comfortable holding here given its fundamental strength.
Unlock Premium - Try 5i Free